News & Discoveries

January 31, 2023

20-Year Study Shows Advances in Care Have Improved Outcomes for Newborns with Congenital Heart Disease (CHD)Increasing a newborn’s blood pressure after heart surgery may reduce brain injuries and increase survival for infants.

January 30, 2023

UCSF-Led Study Shows Benzos, Antidepressants, Ambien May Impact CognitionSleep medications may increase risk of dementia for white people, though the type and amount of medication may also explain the higher probability.

January 12, 2023

On the operating table and inside the lab of a rising star in cancer neurosurgery.On the operating table and inside the lab of a rising star in cancer neurosurgery.

January 12, 2023

Could psychedelics become mainstream medicines?Could psychedelics become mainstream medicines?

January 04, 2023

UCSF-Led Study Shows Extensive Resection Results in Longer Survival for Glioma PatientsResecting brain tumors called gliomas as much as possible soon after diagnosis offers a distinct survival advantage when looking at the disease trajectory 10 years later, find UCSF researchers.

December 20, 2022

UCSF Researchers Identify the Cellular Source of Recurrent GliomaThrough decades of biobanking at UCSF, researchers were able to comprehensively map intra-cellular signaling in the cells of recurrent glioblastoma, identifying novel cell-extrinsic therapeutic targets.

November 30, 2022

36 UCSF researchers rank in the top 1 percent for impact in their fields, according to a new analysis of research citations by science and intellectual property company Clarivate.

November 28, 2022

UCSF Experts Address CTAD Conference on Pharma-Free Intervention; Patient Data Repository; First Trial of svPPA TreatmentUCSF Experts Present Research at the Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference in San Francisco.

November 21, 2022

UCSF-VA Study Shows Psychiatric Disorders Increase Risks for Deaths, HospitalizationsRisk of death or hospitalization from COVID-19 were found to be greater for patients with PTSD.

November 15, 2022

Discovery May Point to New Therapeutic Approach for Common Neurodegenerative DisordersThe brains of people with Down syndrome develop the same neurodegenerative tangles and plaques associated with Alzheimer’s disease and frequently demonstrate signs of the neurodegenerative disorder in their forties or fifties. A new study shows that these tangles and plaques are driven by the same amyloid beta (Aß) and tau prions as Alzheimer’s disease.